scispace - formally typeset
A

Alessandra Bolotta

Researcher at University of Bologna

Publications -  25
Citations -  564

Alessandra Bolotta is an academic researcher from University of Bologna. The author has contributed to research in topics: Proinflammatory cytokine & Autism. The author has an hindex of 11, co-authored 24 publications receiving 435 citations.

Papers
More filters
Journal ArticleDOI

Oxidative stress and erythrocyte membrane alterations in children with autism: correlation with clinical features

TL;DR: Some Au clinical features appear to be correlated with these findings; in particular, hyperactivity score appears to be related with some parameters of the lipidomic profile and membrane fluidity, which could prompt the development of palliative therapeutic protocols.
Journal ArticleDOI

Oxidative Stress in Autistic Children Alters Erythrocyte Shape in the Absence of Quantitative Protein Alterations and of Loss of Membrane Phospholipid Asymmetry

TL;DR: Red blood cells from people affected by autism spectrum disorders (ASDs) are analyzed and RBC shape alterations were independent of the anticoagulant used (Na2-EDTA or heparin) and of different handling procedures preceding glutaraldehyde fixation, thus suggesting that they were not artefactual.
Journal ArticleDOI

Perspective Biological Markers for Autism Spectrum Disorders: Advantages of the Use of Receiver Operating Characteristic Curves in Evaluating Marker Sensitivity and Specificity

TL;DR: Receiver Operating Characteristic (ROC) analysis is applied to some of the previously published data and discusses the increased diagnostic value of combining more variables in one ROC curve analysis, and the use of biomarkers as a tool for advancing the understanding of nonsyndromic ASD.
Journal ArticleDOI

Quantitation of plasma thiamine, related metabolites and plasma protein oxidative damage markers in children with autism spectrum disorder and healthy controls

TL;DR: Autistic children had normal plasma and urinary thiamine levels whereas plasma TPP concentration was decreased, and the latter may be linked to abnormal tissue handling and/or absorption from gut microbiota of TPP which warrants further investigation.